NHS to Offer World-First Blood Cancer Treatment
The NHS in the UK has announced that it will provide a pioneering blood cancer treatment, which is a world first for patient care. The treatment, called chimeric antigen receptor T-cell therapy, involves genetically modifying immune cells to kill cancer cells in patients with some blood cancers, like lymphoma and leukemia.
The pioneering treatment, which is personalized for each patient and involves the removal and alteration of their own T cells that are then returned to the body to hunt and destroy cancer, is powerful and expensive to make. Clinical trials so far have had astonishing success, with some patients going into full remission even when no other treatment worked.
The fact that the NHS will now routine offer this therapy means that patients in the UK who are eligible will be able to benefit from the life-saving treatment which has the potential to transform lives for those with aggressive or resistant blood cancers.
Key Points:
First time treatment available on NHS as standard care.
Provides a glimmer of hope for patients with few options.
Represents a big step forward in personalized cancer treatment.
No comments:
Post a Comment